[HTML][HTML] Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases

HS Shin, BG Jun, SW Yi - Clinical and Molecular Hepatology, 2022 - ncbi.nlm.nih.gov
Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic
factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver …

N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism

Y Wang, J Wang, X Li, X Xiong, J Wang, Z Zhou… - Nature …, 2021 - nature.com
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is
characterized by high recurrence and heterogeneity, yet its mechanism is not well …

Antitumor effects and mechanisms of metabolic syndrome medications on hepatocellular carcinoma

K Oura, A Morishita, J Tani, T Masaki - Journal of Hepatocellular …, 2022 - Taylor & Francis
Liver cancer has a high incidence and mortality rate worldwide, with hepatocellular
carcinoma (HCC) being the most common histological type. With the decrease in the …

Metabolically (un) healthy obesity and risk of obesity-related cancers: a pooled study

M Sun, J Fritz, C Häggström, T Bjørge… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Studies of obesity with or without metabolic aberrations, commonly termed
metabolically unhealthy or healthy obesity, in relation to cancer risk are scarce. Methods We …

Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the …

DK Barupal, ML Ramos, AA Florio… - … journal of cancer, 2024 - Wiley Online Library
In pre‐disposed individuals, a reprogramming of the hepatic lipid metabolism may support
liver cancer initiation. We conducted a high‐resolution mass spectrometry based untargeted …

Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study

B Xia, J Peng, DT Enrico, K Lu, EC Cheung, Z Kuo… - BMC cancer, 2021 - Springer
Abstract Background & Aims Little is known on the gender-specific effect and potential role
of non-linear associations between metabolic syndrome (MetS) components and liver …

Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study

Z Liang, Z Zhang, X Tan, P Zeng - Frontiers in Oncology, 2023 - frontiersin.org
Aim To investigate the causal relationship of serum lipid indicators and lipid-lowering drugs
with the risk of liver cancer using Mendelian randomization study. Methods A two-sample …

Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

G Nagel, T Bjørge, A Jaensch, RS Peter… - … Journal of Cancer, 2021 - Wiley Online Library
To explore the largely unknown etiology of small intestine cancer, we examined metabolic
factors and risk of small intestine cancer overall and by subtypes. Among 404 220 women …

The inverse association of body mass index with lung cancer: exploring residual confounding, metabolic aberrations and within-person variability in smoking

AM Wood, H Jonsson, G Nagel, C Häggström… - … Biomarkers & Prevention, 2021 - AACR
Background: The inverse observational association between body mass index (BMI) and
lung cancer risk remains unclear. We assessed whether the association is explained by …

Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng‐Tongji cohort

J Lyu, X Guan, Y Zhou, H Guo… - Journal of Evidence …, 2023 - Wiley Online Library
Aim Hepatobiliary and pancreatic (HBP) cancers are among the deadliest malignancies.
The objective of the study is to build cost‐effective models to identify high‐risk individuals for …